Par Pharmaceuticals Companies Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Par Pharmaceuticals Companies Inc

Sort by

Viewing results 1‒25 of 6237

Covid-19 vaccines
EU delays approval of Novavax’s revised Covid jab
...“We have made tremendous progress in strengthening the financial position of the company,” it added....
October 15, 2023
Covid-19 vaccines
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
April 15, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
...Any rumours that the company is at risk of defaulting are “flatly untrue”, he said....
April 9, 2024
Johnson & Johnson Co Inc
Johnson & Johnson buys device maker Shockwave for $13.1bn
...Shockwave’s technology has treated approximately 400,000 patients globally, the company said....
April 5, 2024
Mergers & Acquisitions
EU wrong to block Illumina’s $8bn takeover of Grail, says court adviser
...Illumina said the company agreed “with the advocate general that the European Commission’s assertion of jurisdiction over this merger was improper”. Illumina bought Grail in 2021....
March 21, 2024
Corporate bonds
Reading small print for fun and profit
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
March 7, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Behind the Money podcast17 min listen
Can WeightWatchers survive the Wegovy era?
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
April 10, 2024
LexReddit Inc
Reddit wants its users’ money -- but not their input Premium content
...Among the surprises: the company’s investments in bitcoin and ether and the inclusion of entities affiliated with OpenAI’s Sam Altman, Silicon Valley networker par excellence, among the biggest investors...
February 23, 2024
Medical science
UK approves Crispr gene editing therapy in global first
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
November 16, 2023
LexPfizer Inc
Pfizer: pharma group needs weight loss drug to secure post-Covid future Premium content
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
December 13, 2023
LexApple Inc
Apple, the world’s most valuable stock, is about to start growing again Premium content
...The company may have missed out on the early flush of AI hype but it has also avoided rushing out a sub-par product that might harm its reputation....
January 3, 2024
Pfizer Inc
Pfizer shares tumble on weak forecast for 2024 revenues
...Pfizer shares tumbled more than 8 per cent after the US drugmaker forecast 2024 revenues that were below consensus estimates, as the company attempts to chart a future for growth without blockbuster Covid...
December 13, 2023
Hasbro Inc
Hasbro: slowdown in sales spells trouble in toy land Premium content
...The stock is trading on 14 times forward earnings, on a par with Mattel. This seems overpriced given that Mattel has fared better sales-wise....
December 12, 2023
Coronavirus treatment
Expired Pfizer Covid antiviral drugs set to cost Europe $2.2bn, data shows
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
January 1, 2024
Pfizer Inc
Pfizer drops plan for twice-daily obesity pill due to side effects
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
December 1, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
Plastic pollution
World Bank and Citi launch $100mn plastic credits bond
...The two recycling projects generate and sell plastic and carbon offset credits to big companies that use large amounts of plastic....
January 26, 2024
Anjli Raval
Competent jerks have a shelf life in the office
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
January 14, 2024
LexFood & Beverage
Pepsi/obesity drugs: snack pack will withstand economies of scales Premium content
...Packaged food companies have built strong and trusted brands over decades....
October 10, 2023
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
October 9, 2023
LexBoots UK Ltd
Boots: one step closer to the block Premium content
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
November 24, 2023
Driverless vehicles
China challenges the west for driverless car supremacy
...But as of September last year, autonomous vehicles in China had driven a cumulative total of 70mn kilometres, on a par with the US, according to data from Bain....
January 31, 2024
Scoreboard
The Pop Tarts effect and US college football Premium content
...Highlights Amer Sports, the parent company of tennis racket maker Wilson, hiking and skiing equipment company Salomon, and high-end outdoor gear brand Arc’teryx, has filed to list on the New York Stock...
January 6, 2024
Drugs research
Roche agrees $7.1bn deal for Telavant to boost drug pipeline
...Large pharmaceutical companies are increasingly interested in immunology — tackling diseases often caused by an overactive immune system — because of the large number of affected patients....
October 23, 2023
LexJune Yoon
The Lex Newsletter: China weighs up fast-food stocks vs pharma stocks Premium content
...The fast-food industry alone is worth about $180bn, on par with its market size in the US. This year, strong demand in China has boosted McDonald’s group earnings and same-store sales growth....
October 18, 2023
BioNTech
BioNTech writes down €900mn on Covid-19 vaccines
...Albert Bourla, Pfizer’s chief executive, said the company’s product portfolio, apart from Covid medicines, remained strong, with the company expecting revenues from the rest of the business to grow between...
October 16, 2023

Previous pagePage 1 of 250Next page